Article content continued

Those latter strains are produced by Bedrocan Cannabis Corp., and they say a lot about the people behind the company: They’re scientists, and all they want to do is produce a standardized, pharmaceutical-grade product that’s better than the competition.

“We don’t call it ‘Maui Wowie,’” said chief executive Marc Wayne.

Bedrocan’s Dutch parent company has been the sole supplier of medicinal marijuana to the Netherlands government since 2001, and has now brought its growing act to Canada. The Financial Post toured its soon-to-be-open production facility in a secret Toronto location last week, and it is a model of efficiency: 32 small grow rooms spread over a 50,000-square-foot building; two huge vegetative rooms; a giant vault for storage and freezing; and about 120 security cameras that monitor every inch of the space.

“We’re trying to make athletes of our plants,” said Tjalling Erkelens, the founder of Bedrocan BV, during the tour. “This is the most advanced marijuana facility in the world.”

In comparing Bedrocan to many of its competitors, there’s no doubt some companies in the nascent industry are targeting the medical marijuana market by distancing themselves from pot’s underground origins, while others are eagerly embracing the plant’s recreational culture.

The latter strategy seems rather odd given that last anyone checked, recreational use is still illegal in this country. Bedrocan is the world’s most experienced medical cannabis grower by a wide margin, and should have a huge marketing advantage over less-serious players.